Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2017 (2017), Article ID 4159727, 3 pages
https://doi.org/10.1155/2017/4159727
Case Report

Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil

1Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Ube, Japan
2Division of Endocrinology, Metabolism, Hematological Science and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Japan

Correspondence should be addressed to Makoto Kubo

Received 27 May 2017; Accepted 12 July 2017; Published 14 September 2017

Academic Editor: Shoichiro Ikuyama

Copyright © 2017 Takashi Nawata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Fukaya, S. Yasuda, T. Hashimoto et al., “Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases,” Rheumatology, vol. 47, no. 11, pp. 1686–1691, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Lambotte, M. Khellaf, H. Harmouche et al., “Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome,” Medicine, vol. 85, no. 3, pp. 169–182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Paliga, N. Shahbazi, C. Gonsalves, J. Bormanis, and R. Padmore, “Trilineage myelodysplasia and hemophagocytosis associated with systemic lupus erythematosus,” American Journal of Hematology, vol. 87, no. 5, pp. 529-530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. B. J. Uttenthal, D. M. Layton, T. J. Vyse, and B. E. Schreiber, “Clinical problem-solving. The wolf at the door,” New England Journal of Medicine, vol. 366, no. 23, pp. 2216–2221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Sugiyama, K. Minegishi, N. Hamada et al., “Successful treatment of a patient with refractory haemophagocytic syndrome in systemic lupus erythematosus with mycophenolate mofetil,” Modern Rheumatology Case Reports, vol. 1, no. 2, pp. 79–83, 2017. View at Publisher · View at Google Scholar
  6. M. Petri, A. M. Orbai, G. S. Alarcón et al., “Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 64, no. 8, pp. 2677–2686, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-I. Henter, A. Horne, M. Aricó et al., “HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis,” Pediatric Blood & Cancer, vol. 48, no. 2, pp. 124–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. C. Allison and E. M. Eugui, “Mycophenolate mofetil and its mechanisms of action,” Immunopharmacology, vol. 47, no. 2-3, pp. 85–118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Chen, J. Sun, K. Zou, Y. Yang, and G. Liu, “Treatment for lupus nephritis: an overview of systematic reviews and meta-analyses,” Rheumatology International, vol. 37, no. 7, pp. 1089–1099, 2017. View at Publisher · View at Google Scholar
  10. B. H. Hahn, M. McMahon, A. Wilkinson et al., “American College of Rheumatology guidelines for screening, case definition, treatment and management of lupus nephritis,” Arthritis Care & Research, vol. 64, no. 6, pp. 797–808, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. G. S. Schulert and A. A. Grom, “Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies,” Annual Review of Medicine, vol. 66, no. 1, pp. 145–159, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Dörner and P. E. Lipsky, “Beyond pan-B-cell-directed therapy—new avenues and insights into the pathogenesis of SLE,” Nature Reviews Rheumatology, vol. 12, no. 11, pp. 645–657, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Kumakura, H. Ishikura, M. Kondo, Y. Murakawa, J. Masuda, and S. Kobayashi, “Autoimmune-associated hemophagocytic syndrome,” Modern Rheumatology, vol. 14, no. 3, pp. 205–215, 2004. View at Publisher · View at Google Scholar
  14. E. J. ter Borg, G. Horst, E. J. Hummel, P. C. Limburg, and C. G. Kallenberg, “Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study,” Arthritis & Rheumatism, vol. 33, no. 5, pp. 634–643, 1990. View at Publisher · View at Google Scholar · View at Scopus